Fig. 1From: Exploring pharmacological approaches for managing cytokine storm associated with pneumonia and acute respiratory distress syndrome in COVID-19 patientsCytokine storm and potential pharmacological targets in COVID-19-related ARDS and pneumonia. IL, interleukin; TNF, tumor necrosis factor, GCSF, granulocyte colony-stimulating factor; JAK, Janus kinase; MCP, monocyte chemoactractant protein; MIP, macrophage inflammatory proteinBack to article page